Literature DB >> 35738900

Ultra-high-diversity factorizable libraries for efficient therapeutic discovery.

Zheng Dai1, Sachit D Saksena1, Geraldine Horny2, Christine Banholzer2, Stefan Ewert2, David K Gifford1.   

Abstract

The successful discovery of novel biological therapeutics by selection requires highly diverse libraries of candidate sequences that contain a high proportion of desirable candidates. Here we propose the use of computationally designed factorizable libraries made of concatenated segment libraries as a method of creating large libraries that meet an objective function at low cost. We show that factorizable libraries can be designed efficiently by representing objective functions that describe sequence optimality as an inner product of feature vectors, which we use to design an optimization method we call stochastically annealed product spaces (SAPS). We then use this approach to design diverse and efficient libraries of antibody CDR-H3 sequences with various optimized characteristics.
© 2022 Dai et al.; Published by Cold Spring Harbor Laboratory Press.

Entities:  

Year:  2022        PMID: 35738900      PMCID: PMC9528983          DOI: 10.1101/gr.276593.122

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.438


  21 in total

Review 1.  Synthetic DNA Synthesis and Assembly: Putting the Synthetic in Synthetic Biology.

Authors:  Randall A Hughes; Andrew D Ellington
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-01-03       Impact factor: 10.005

2.  Sequence logos: a new way to display consensus sequences.

Authors:  T D Schneider; R M Stephens
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

Review 3.  Adeno-associated virus vector as a platform for gene therapy delivery.

Authors:  Dan Wang; Phillip W L Tai; Guangping Gao
Journal:  Nat Rev Drug Discov       Date:  2019-05       Impact factor: 84.694

4.  Biophysical properties of the clinical-stage antibody landscape.

Authors:  Tushar Jain; Tingwan Sun; Stéphanie Durand; Amy Hall; Nga Rewa Houston; Juergen H Nett; Beth Sharkey; Beata Bobrowicz; Isabelle Caffry; Yao Yu; Yuan Cao; Heather Lynaugh; Michael Brown; Hemanta Baruah; Laura T Gray; Eric M Krauland; Yingda Xu; Maximiliano Vásquez; K Dane Wittrup
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

5.  T Cell Receptor Engineering and Analysis Using the Yeast Display Platform.

Authors:  Sheena N Smith; Daniel T Harris; David M Kranz
Journal:  Methods Mol Biol       Date:  2015

6.  A strategy for risk mitigation of antibodies with fast clearance.

Authors:  Isidro Hötzel; Frank-Peter Theil; Lisa J Bernstein; Saileta Prabhu; Rong Deng; Leah Quintana; Jeff Lutman; Renuka Sibia; Pamela Chan; Daniela Bumbaca; Paul Fielder; Paul J Carter; Robert F Kelley
Journal:  MAbs       Date:  2012 Nov-Dec       Impact factor: 5.857

Review 7.  Synthetic approach to the generation of antibody diversity.

Authors:  Hyunbo Shim
Journal:  BMB Rep       Date:  2015-09       Impact factor: 4.778

8.  Five computational developability guidelines for therapeutic antibody profiling.

Authors:  Matthew I J Raybould; Claire Marks; Konrad Krawczyk; Bruck Taddese; Jaroslaw Nowak; Alan P Lewis; Alexander Bujotzek; Jiye Shi; Charlotte M Deane
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-14       Impact factor: 11.205

9.  Antibody complementarity determining region design using high-capacity machine learning.

Authors:  Ge Liu; Haoyang Zeng; Jonas Mueller; Brandon Carter; Ziheng Wang; Jonas Schilz; Geraldine Horny; Michael E Birnbaum; Stefan Ewert; David K Gifford
Journal:  Bioinformatics       Date:  2020-04-01       Impact factor: 6.937

10.  Golden gate shuffling: a one-pot DNA shuffling method based on type IIs restriction enzymes.

Authors:  Carola Engler; Ramona Gruetzner; Romy Kandzia; Sylvestre Marillonnet
Journal:  PLoS One       Date:  2009-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.